Latest Research
Stay up-to-date with key advancements in eosinophil research through our monthly highlights, showcasing select publications that reflect the most recent developments in both basic and clinical science. These featured studies offer a snapshot of the latest contributions to our understanding of eosinophil biology and its clinical implications.
October 2024
To view all publications from October 2024, click here.
Cluster Analysis Identifies Patients With Severe Eosinophilic Asthma Who Achieve Super-Response and Remission With Mepolizumab
Di Bona D; et al
Clin Exp Allergy
Differential Tfh cell phenotypes distinguish IgE-mediated milk allergy from eosinophilic esophagitis in children
Lozano-Ojalvo D; et al
J Allergy Clin Immunol
Activated eosinophils in early life impair lung development and promote long-term lung damage
Raftery AL; et al
Mucosal Immunol
First-Line Antituberculosis Drug Challenge Reactions in Drug Reaction With Eosinophilia and Systemic Symptoms Syndrome in an HIV Endemic Setting
Porter M; et al
J Allergy Clin Immunol Pract
Eosinophil specialization is regulated by exposure to the esophageal epithelial microenvironment
Dunn JLM; et al
J Leukoc Biol
September 2024
Click to expand
Persistent Desmoglein-1 downregulation and Periostin accumulation in histologic remission of Eosinophilic Esophagitis
Hoelz H; et al
J Allergy Clin Immunol
CSF1-dependent macrophage support matrisome and epithelial stress-induced keratin remodeling in Eosinophilic esophagitis
Benson TM; et al
Mucosal Immunol
Eosinophilia and Adverse Effects of Dupilumab for Respiratory Indications: A Real-World Setting.
Li SH; et al
J Allergy Clin Immunol Pract
A multicentre comparative cohort study of severe maculopapular exanthema and drug reaction with eosinophilia and systematic symptoms
Copaescu AM; et al
J Allergy Clin Immunol Pract
Tissue-specific inducible IL-33 expression elicits features of eosinophilic esophagitis
Pyon GC; et al
J Allergy Clin Immunol
Twice-Yearly Depemokimab in Severe Asthma with an Eosinophilic Phenotype
Jackson DJ; et al
N Engl J Med
One-food versus 4-food elimination diet for pediatric eosinophilic esophagitis: A multisite randomized trial
Kliewer KL; et al
J Allergy Clin Immunol
August 2024
Click to expand
Advancing towards a unified eosinophil signature from transcriptional profiling
Chhiba KD; et al
J Leukoc Biol
Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study
Crimi C; et al
J Allergy Clin Immunol Pract
Metabolic dysfunction mediated by HIF-1alpha contributes to epithelial differentiation defects in eosinophilic esophagitis
Ryan S; et al
J Allergy Clin Immunol
Association of HLA-B*13:01 with DRESS and HLA-A*31:01 with Eosinophilia in SJS/TEN induced by carbamazepine
Kim HJ; et al
J Leukoc Biol
July 2024
Click to expand
Biologic therapy in rare eosinophil-associated disorders: remaining questions and translational research opportunities
Khoury P; et al
J Leukoc Biol
Long-term durability between parent and child patient-reported outcomes in eosinophilic esophagitis
Martin LJ; et al
J Allergy Clin Immunol